「SCORED trial」熱門搜尋資訊

SCORED trial

「SCORED trial」文章包含有:「SotagliflozininPatientswithDiabetesandChronicKidney...」、「EffectofSotagliflozinonCardiovascularandRenalEvents...」、「SCOREDTrial」、「NCT03315143」、「SotagliflozinandKidneyOutcomes」、「ASecondaryAnalysisoftheSCOREDTrial」、「DidtheSCOREDTrialGetExtraPointsforKidney...」、「SotagliflozinSlowsCKDProgressioninPatientsWithT2DM」

查看更多
Sotagliflozininpefa
Provide From Google
Sotagliflozin in Patients with Diabetes and Chronic Kidney ...
Sotagliflozin in Patients with Diabetes and Chronic Kidney ...

https://www.nejm.org

We conducted a multicenter, double-blind trial in which patients with type 2 diabetes mellitus (glycated hemoglobin level, ≥7%), chronic kidney ...

Provide From Google
Effect of Sotagliflozin on Cardiovascular and Renal Events ...
Effect of Sotagliflozin on Cardiovascular and Renal Events ...

https://www.acc.org

The SCORED trial showed that sotagliflozin has salutary effects on CV outcomes among patients with T2DM and CKD. Description: The goal of ...

Provide From Google
SCORED Trial
SCORED Trial

https://www.inpefahcp.com

Learn about the SCORED trial in patients with type 2 diabetes mellitus, chronic kidney disease, and cardiovascular risk factors, including a history of ...

Provide From Google
NCT03315143
NCT03315143

https://clinicaltrials.gov

沒有這個頁面的資訊。

Provide From Google
Sotagliflozin and Kidney Outcomes
Sotagliflozin and Kidney Outcomes

https://journals.lww.com

SCORED was a multicenter, randomized trial evaluating cardiorenal outcomes with sotagliflozin versus placebo in 10,584 patients with type 2 diabetes and CKD.

Provide From Google
A Secondary Analysis of the SCORED Trial
A Secondary Analysis of the SCORED Trial

https://pubmed.ncbi.nlm.nih.go

Methods: SCORED was a multicenter, randomized trial evaluating cardiorenal outcomes with sotagliflozin versus placebo in 10,584 patients with ...

Provide From Google
Did the SCORED Trial Get Extra Points for Kidney ...
Did the SCORED Trial Get Extra Points for Kidney ...

https://journals.lww.com

The two most extensive trials evaluating cardiovascular outcomes in patients receiving sotagliflozin include the SOLOIST-WHF and SCORED trials.

Provide From Google
Sotagliflozin Slows CKD Progression in Patients With T2DM
Sotagliflozin Slows CKD Progression in Patients With T2DM

https://www.uspharmacist.com

The trial revealed that use of the dual sodium-glucose cotransporter (SGLT) 1 and 2 inhibitor sotagliflozin enhances kidney and cardiorenal outcomes in ...